encorafenib,futibatinib,cetuximab,pembrolizumab
pfizer,merck,eli lilly,pierre fabre,otsuka,merck
['futibatinib', 'nsclc', 'seamark', 'pancreatic', 'sclc']
 summary of first day #asco22 kras in #pancreaticcancer futibatinib in fgfr2 #btcs no use of vegfinh in #muc
#breakwater and #seamark will shed light on #braf #ccr dor as surrogate of pfs os combo #io and #tki 2l and #io #lag3 1l #nsclc 
Medical Oncologist MD, BSc Vall d'Hebrón @vallhebron @VHIO

President Secció Metges MIR del COMB @COMBarcelona 

Asesor en @SalutUIC

#oncology #research #MIR